[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc. (REGN): Among the Most Promising Cancer Stocks According to Hedge Funds",
    "summary": "We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other promising cancer stocks. According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, […]",
    "url": "https://finnhub.io/api/news?id=6570de4eca1a938b50525898d33e3db16b719eea7d31763363e3d8b5b24ce689",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732377045,
      "headline": "Regeneron Pharmaceuticals, Inc. (REGN): Among the Most Promising Cancer Stocks According to Hedge Funds",
      "id": 131591726,
      "image": "https://s.yimg.com/ny/api/res/1.2/jMekiCT4mZ2_S7szsjNT5A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/9b67531d4ce9e2fbb21fef60675f48d3",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other promising cancer stocks. According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, […]",
      "url": "https://finnhub.io/api/news?id=6570de4eca1a938b50525898d33e3db16b719eea7d31763363e3d8b5b24ce689"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals (NASDAQ:REGN) shareholders have earned a 15% CAGR over the last five years",
    "summary": "Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) shareholders might understandably be very concerned that the share...",
    "url": "https://finnhub.io/api/news?id=2288ea1bec86933f13ae99c287a39c34131488e8cdba1480e3dac43c549dc3c6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732370416,
      "headline": "Regeneron Pharmaceuticals (NASDAQ:REGN) shareholders have earned a 15% CAGR over the last five years",
      "id": 131591727,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) shareholders might understandably be very concerned that the share...",
      "url": "https://finnhub.io/api/news?id=2288ea1bec86933f13ae99c287a39c34131488e8cdba1480e3dac43c549dc3c6"
    }
  },
  {
    "ts": null,
    "headline": "Dell, Autodesk, And CrowdStrike Headline Earnings Reports In Holiday-Shortened Week",
    "summary": "Stay ahead of the market with Seeking Alpha's Wall Street Week Ahead newsletter, previewing key events like earnings reports, IPOs, and economic indicators.",
    "url": "https://finnhub.io/api/news?id=0f4dd2a87110b2897fd644e58e8d3265e49aae59a4f04e025c596c94e1153446",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732359600,
      "headline": "Dell, Autodesk, And CrowdStrike Headline Earnings Reports In Holiday-Shortened Week",
      "id": 131589479,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Stay ahead of the market with Seeking Alpha's Wall Street Week Ahead newsletter, previewing key events like earnings reports, IPOs, and economic indicators.",
      "url": "https://finnhub.io/api/news?id=0f4dd2a87110b2897fd644e58e8d3265e49aae59a4f04e025c596c94e1153446"
    }
  }
]